Author's Note: Last featured 10/26/23 at $586.37. Gained 54% since that date. The Chart of the Day belongs to the drug manufacturer Eli Lilly (LLY) . I found the stock by using Barchart's powerful screening...
Which one of these potential disruptors is the better buy?
The stock may seem expensive right now, but that may not be the case in a few years.
/CNW/ - Eli Lilly Canada Inc. announced today that Health Canada authorized Ebglyss™ (lebrikizumab), a targeted IL-13 inhibitor, for the treatment of...
The Vanguard S&P 500 ETF includes many of the most influential stocks in the world, such as Microsoft, Apple, Nvidia, Alphabet, and Amazon.
A new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep
Lilly is a good pick...but this one is better.
The World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines
The Alzheimer’s treatment market is large and expected to grow.
This year, the financial landscape has been shaped by high interest rates and tenacious inflation, a combination of scenarios that have significantly influenced various sectors of the economy. For investors,...